Skip to content
Company Analysis

Treace Medical Concepts, Inc. TMCI

A comprehensive view of key metrics, scores, and financial health for Treace Medical Concepts, Inc.

Overview of Treace Medical Concepts, Inc.

TMCI NMS
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Small Cap
Treace Medical Concepts, Inc. (TMCI), is a Small Cap company, in the Medical Devices industry, last closed at $4.63, about 25.7% overvalued vs fair value, -35.9% 1Y return, ranked 478/1145 in sector.
Metrics Rev Growth 1.6% ROE -58.9% Gross Margin 79.8% Div Yield 0.00%
USD 4.63
-3.74%
(Delayed)
• Vol 90d: 82.9%
52-Week Range
Market Cap
$302.31M
Enterprise Value
$362.39M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Fair
Growth
Weak
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Fair
Completeness: 100%
Confidence: 60%
Updated: Sep 12
Top Beats

Quick Facts

Website https://www.treace.com
HQ Ponte Vedra, FL
Employees 477
Fiscal year Dec 31

Next Events

Earnings Nov 5 Estimated

Fair Value Snapshot

Bear Base Bull
$3
$3
$4
Current: $4.63 -26% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$212.7M
1.6%%
Gross Profit
$169.8M
0.9%%
Operating Income (GAAP)
$-54.2M
2.8%%
EBITDA
$-43.1M
-2.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
79.8%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Treace Medical Concepts, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
58
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Elite Gross Margins Gross margin quality is top-tier vs peers (score 0.85). This signals strong consumable attach-rate economics.
  • Stable Gross Margin Profile Gross margin stability is strong (score 0.90). Low volatility confirms durable consumable pricing.

Key risks

  • Weak Capital Return Profile Capital return quality is below peers (score 0.39). Low ROIC raises questions about M&A discipline and pipeline ROI.
  • Elevated Leverage Leverage is elevated vs peers (score 0.23). High net debt/EBITDA limits the balance sheet's acquisition firepower.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
87
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 87% Coverage
Trade-Off Triangle Visualization A ternary plot showing TMCI's balance between Growth (32.3%), Profitability (44.2%), and Safety (23.4%). Growth 32% Safety 23% Profitability 44%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

37th percentile vs peers
38
Key Signals
Revenue CAGR 3Y 14.5% 65p Rev Growth YoY 1.6% 37p EPS Growth YoY -3.9% 30p Asset Growth YoY -12.2% 23p TSR -67.1% 5p
Strengths
  • Gross Profit Margin in top 20% of peers (79.8%, 89th percentile)
Risks

No significant risks identified for this axis.

Profitability

51th percentile vs peers
52
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

27th percentile vs peers
27
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Treace Medical Concepts, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$3.44
- - -
-25.7% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000